Suchergebnisse - "Lambden, Simon"

PubPharm (46)

1

Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH) : a double-blind, randomised, controlled, phase 2b trial

enthalten in: The Lancet. Respiratory medicine | 2023

von François, B. | Lambden, S. | Fivez, T. | +50

CommentIn: Lancet Respir Med. 2023 Oct;11(10):855-857. - PMID 37269869

2

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2023

von DERIVE MARC | SALCEDO-MAGGUILLI MARGARITA | GARAUD JEAN-JACQUES | +2

3

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support : the ESSENTIAL randomised, double-blind trial

enthalten in: EClinicalMedicine | 2023

von François, B. | Lambden, S. | Garaud, J. | +20

4

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2023

von DERIVE MARC | SALCEDO-MAGGUILLI MARGARITA | GARAUD JEAN-JACQUES | +2

5

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2021

von DERIVE MARC | SALCEDO-MAGGUILLI MARGARITA | GARAUD JEAN-JACQUES | +2

6

TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2021

von DERIVE MARC | SALCEDO-MAGGUILLI MARGARITA | GARAUD JEAN-JACQUES | +2

7

sTREM-1 is a specific biomarker of TREM-1 pathway activation

enthalten in: Cellular & molecular immunology | 2021

von Jolly, L. | Carrasco, K. | Salcedo-Magguilli, M. | +8

8

Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19

enthalten in: Bioscience reports | 2021

von de Nooijer, A. | Grondman, I. | Lambden, S. | +10

9

Rationale and protocol for the efficacy, safety and tolerability of nangibotide in patients with septic shock (ASTONISH) phase IIb randomised controlled trial

enthalten in: BMJ open | 2021

von Francois, B. | Lambden, S. | Gibot, S. | +9

10

Endothelial cell regulation of systemic haemodynamics and metabolism acts through the HIF transcription factors

enthalten in: Intensive care medicine experimental | 2021

von Lambden, S. | Cowburn, A. | Macias, D. | +5

1
2
3
4
5
Nächster »
[5]